PlantForm Strikes Deal For Brazilian Pembrolizumab

Signs Agreement With Bio-Manguinhos/Fiocruz To Develop Keytruda Rival

 
• By David Wallace
  
Deal Handshake Brazil Canada Flags
Canada’s Plantform has struck a deal to develop a pembrolizumab biosimilar • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business